Although anti-VEGF antibody was produced in the tumor group mice, tumor growth was significantly lower in the vaccine group mice (P<0.001), and no tumor growth was observed in this group until seven weeks after inoculation (Figure. The gene discussed is VEGFA; the disease is neoplasm.